Aeromonas spp. and traveler's diarrhea: Clinical features and antimicrobial resistance
- Jordi Vila(corresponding author),
- ,
- Francisco Gallardo,
- Martha Vargas,
- Lara Soler,
- Maria José Figueras
- Hospital Clinic Barcelona,
- Hospital Clínic – Universitat de Barcelona,
- ,
- Universitat Rovira i Virgili
Open access
Publication Information
Output type
Original language
EnglishPages from-to (Number of pages)
Pages 552-555 (4 pages)Journal (Volume, Issue Number)
Emerging Infectious Diseases (Volume 9, Issue 5)Publication milestones
- Published - 01/05/2003
Publication status
ISSN
1080-6040Publication IDs
- Scopus: 0038415875
- PubMed: 12737738
Abstract
Traveler's diarrhea is the most common health problem of international travelers. We determined the prevalence of Aeromonas spp. associated with traveler's diarrhea and analyzed the geographic distribution, clinical features, and antimicrobial susceptibility. Aeromonas spp. were isolated as a cause of traveler's diarrhea in 18 (2%) of 863 patients. A. veronii biotype sobria was isolated in nine patients, A. caviae in seven patients, and A. jandaei and A. hydrophila in one patient each. Aeromonas spp. were isolated with a similar prevalence in Africa, Latin America, and Asia. Watery and persistent diarrhea, fever, and abdominal cramps were common complaints. All strains were resistant to ampicillin; showed variable resistance to chloramphenicol, tetracycline, and cotrimoxazole; and were susceptible to cefotaxime, ciprofloxacin, and nalidixic acid. The persistence of symptoms made antimicrobial treatment necessary.
Access to documents
Publication metrics
Metrics
PlumX, opens in new tab
Sustainable Development Goals
- SDG 3 Good Health and Well
